Basic Materials / Specialty ChemicalsTel Aviv
$92040.00
-520.00 (-0.56%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $710.0M · quality 64.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
35/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.0B
P/E
28.1x
↑EV/EBITDA
518.4x
↑ROE
2.9%
↑Gross Margin
30.5%
↑Debt/Equity
1.14
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-10.6%
FCF CAGR
-51.1%
FCF margin
2.4%
FCF / Net income
1.97x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.15B · net income $87.0M · FCF $171.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.15B | $7.15B | $6.84B | $7.54B | $10.02B |
| Net Income | $87.0M | $87.0M | $190.0M | $273.0M | $953.0M |
| EBITDA | $1.34B | $1.34B | $1.43B | $1.71B | $4.06B |
| EPS | 11.60 | 11.60 | 25.30 | 35.79 | 124.93 |
| Gross Margin | 30.5% | 30.5% | 32.9% | 35.4% | 50.2% |
| Operating Margin | 7.5% | 7.5% | 11.2% | 15.7% | 34.6% |
| Net Margin | 1.2% | 1.2% | 2.8% | 3.6% | 9.5% |
| Balance Sheet | |||||
| Debt/Equity | 1.14 | 1.14 | 1.07 | 1.28 | 1.61 |
| Current Ratio | 1.49 | 1.49 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $171.0M | $171.0M | $710.0M | $1.04B | $1.46B |
| Returns | |||||
| ROE | 2.9% | 2.9% | 6.7% | 9.8% | 38.8% |
| Valuation | |||||
| P/E | 28.09 | 28.09 | 3851.38 | 2648.23 | 1012.57 |
| EV/EBITDA | 518.41 | 518.41 | 514.43 | 425.81 | 238.34 |
| P/B | 229.15 | 229.15 | 259.83 | 260.44 | 392.89 |
| Growth & Yield | |||||
| Revenue Growth | 4.6% | 4.6% | -9.2% | -24.8% | — |
| EPS Growth | -54.2% | -54.2% | -29.3% | -71.4% | — |
| Dividend Yield | 0.6% | 0.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
789.6%
EPS terminal req.
$8167.02
Spread vs growth
-843.8%
5Y implied EPS CAGR
285.5%
EPS terminal req.
$9882.09
Spread vs growth
-339.7%
10Y implied EPS CAGR
105.9%
EPS terminal req.
$15915.20
Spread vs growth
-160.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-7.6%
Start / end P/E
3963.2x → 7934.5x
EPS bridge
25.30 → 11.60
Residual
-54.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.